نتایج جستجو برای: coagulation inhibitors

تعداد نتایج: 234093  

ALI AKBAR POURFATHOLLAH, HABIBOLLAH ESMAILI, HASSAN MANSOURI TORGHABEH, MAHMOOD MAHMOODIAN SHOOSHTARI, ZAHRA REZAIE YAZDI,

Patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). In this survey we detected factor V and VIII inhibitor in ten patients with combined deficiency of factors V and VIII from north east of Iran (Khorassan province). It was revealed in our survey that eight patients had both factor V and factor VIII i...

Journal: :medical journal of islamic republic of iran 0
hassan mansouri torghabeh from the 'experimental hematology and blood banking dept, medical sciences school, tarbiat modaresuniversity (t.m. u.), ali akbar pourfathollah from the 'experimental hematology and blood banking dept, medical sciences school, tarbiat modaresuniversity (t.m. u.), mahmood mahmoodian shooshtari the iranian blood transfusion organization research center, tehran zahra rezaie yazdi the departmentof internal medicine, mashhad medical sciences university, mashhad habibollah esmaili 4community medicine and public health department of mashhad medical sciences university, mashhad, iran

patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). in this survey we detected factor v and viii inhibitor in ten patients with combined deficiency of factors v and viii from north east of iran (khorassan province). it was revealed in our survey that eight patients had both factor v and factor viii inhib...

Journal: :Biochemical Society transactions 2005
C T Esmon

Coagulation is triggered by inflammatory mediators in a number of ways. However, to prevent unwanted clot formation, several natural anticoagulant mechanisms exist, such as the antithrombin-heparin mechanism, the tissue factor pathway inhibitor mechanism and the protein C anticoagulant pathway. This review examines the ways in which these pathways are down-regulated by inflammation, thus limiti...

Journal: :The Journal of the Royal College of Physicians of Edinburgh 2014

Journal: :iranian journal of blood and cancer 0
m payandeh medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) n amirifard cancer research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) e sadeghi medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) m sadeghi medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) m choubsaz cancer research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) f noor mohammadi far medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences)

background: hemophilia is the most frequent severe hereditary hemorrhagic disease due to deficiency of coagulation factors viii (hemophilia a) or ix (hemophilia b) in plasma. we aimed to identify patients with hemophilia in kermanshah, iran and assess the incidence of inhibitors in this population and its associated factors. methods: this study was conducted on patients with hemophilia a and b ...

Aliakbar Pourfathollah, Hassan Mansouri Torghabeh, Mahmoud Mahmoudian Shoushtari,

Background: Hemophilia B is a bleeding disorder with a recessive X-linked inheritance pattern, in which the infected individuals have low levels of factor IX in their plasma. Affected individuals may have bleeding episodes after trauma or spontaneously considering the plasma level of factor IX. In order to prevent these episodes and to control bleeding, they should use coagulation factor concen...

Journal: :iranian journal of blood and cancer 0
hassan mansouri torghabeh aliakbar pourfathollah mahmoud mahmoudian shoushtari

background: hemophilia b is a bleeding disorder with a recessive x-linked inheritance pattern, in which the infected individuals have low levels of factor ix in their plasma. affected individuals may have bleeding episodes after trauma or spontaneously considering the plasma level of factor ix. in order to prevent these episodes and to control bleeding, they should use coagulation factor concen...

, E Sadeghi, F Noor Mohammadi Far, M Choubsaz , M Payandeh, M Sadeghi, N Amirifard ,

  Background: Hemophilia is the most frequent severe hereditary hemorrhagic disease due to deficiency of coagulation factors VIII (Hemophilia A) or IX (Hemophilia B) in plasma. We aimed to identify patients with  hemophilia in Kermanshah, Iran and assess the incidence of inhibitors in this population and its associated factors. Methods: This study was conducted on patients with hemophilia...

Journal: :Turkish journal of haematology : official journal of Turkish Society of Haematology 2002
Eberhard F Mammen

mostasis and inflammation are closely related processes. It is recognized that the activation of hemostasis fosters, to a certain extent, inflammation and that inflammation, in turn, activates the hemostasis system. These interrelationships are best illustrated in sepsis, were microorganisms or their release products, most notably cytokines, causing inflammation, activate the hemostasis system....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید